Research / NVT / Fundamental state Inspectable configuration
State dimensions Filing 0001720635-23-000009 General Corporate
Debt relative to revenue 0th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.debt_to_revenue
37.24% · OPTIONAL · VALID
Capex intensity 35th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.58% · OPTIONAL · VALID
Operating cash generation 41th Own-history percentile · N=17
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
13.56% · OPTIONAL · VALID
Share-count growth 87th Own-history percentile · N=15
Evidence method Yoy · gp.fundamentals.shares_outstanding
-0.44% · CORE · VALID
Revenue growth 67th Own-history percentile · N=15
Evidence method Yoy · gp.fundamentals.revenue
18.16% · CORE · VALID
Inventory pressure 16th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
11.92% · OPTIONAL · VALID
Gross margin 26th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.gross_margin
37.70% · CORE · VALID
Operating margin 74th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.operating_margin
15.14% · CORE · VALID
R&D intensity 47th Own-history percentile · N=19
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.08% · OPTIONAL · VALID
SBC intensity 82th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.86% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Sep 30, 2021 10/10 normalized Level 3 Dec 31, 2021 10/10 normalized Level 3 Mar 31, 2022 10/10 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 10/10 normalized Level 3 Mar 31, 2023 10/10 normalized Level 3 Jun 30, 2023 10/10 normalized Level 3 Sep 30, 2023 10/10 normalized Level 3 Dec 31, 2023 10/10 normalized Level 3 Mar 31, 2024 10/10 normalized Level 3 Jun 30, 2024 10/10 normalized Level 3 Sep 30, 2024 10/10 normalized Level 3 Dec 31, 2024 10/10 normalized Level 3 Mar 31, 2025 10/10 normalized Level 3 Jun 30, 2025 10/10 normalized Level 3 Sep 30, 2025 10/10 normalized Level 3 Dec 31, 2025 10/10 normalized Level 3 Mar 31, 2026 10/10 normalized Level 3 Jun 30, 2026 10/10 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 143.81%
Current 37.24%
Delta -106.58% Dilution Increased
Previous -0.98%
Current -0.44%
Delta 0.54% Growth Increased
Previous 15.93%
Current 18.16%
Delta 2.23% Inventory Pressure Decreased
Previous 50.25%
Current 11.92%
Delta -38.34% Margin Decreased
Previous 38.92%
Current 37.70%
Delta -1.22% Profitability Decreased
Previous 16.17%
Current 15.14%
Delta -1.03% R And D Intensity Increased
Previous 1.97%
Current 2.08%
Delta 0.10% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.